MX2012001921A - Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso. - Google Patents

Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso.

Info

Publication number
MX2012001921A
MX2012001921A MX2012001921A MX2012001921A MX2012001921A MX 2012001921 A MX2012001921 A MX 2012001921A MX 2012001921 A MX2012001921 A MX 2012001921A MX 2012001921 A MX2012001921 A MX 2012001921A MX 2012001921 A MX2012001921 A MX 2012001921A
Authority
MX
Mexico
Prior art keywords
fluoroglutamine
methods
preparation
single diastereomers
diastereomers
Prior art date
Application number
MX2012001921A
Other languages
English (en)
Inventor
Hank F Kung
Craig B Thompson
Wenchao Qu
Karl Ploessl
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of MX2012001921A publication Critical patent/MX2012001921A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a diastereómeros simples de 4-fluoroglutamina que tiene un exceso diastereomérico de al menos 80%. También se describen métodos para la preparación de los diastereómeros simples, así como también se describen métodos para usar los diastereómeros simples re 4-fluoroglutamina radioetiquetada como agente trazador.
MX2012001921A 2009-08-14 2010-08-13 Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso. MX2012001921A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23387509P 2009-08-14 2009-08-14
PCT/US2010/045470 WO2011020018A1 (en) 2009-08-14 2010-08-13 Single diastereomers of 4-fluoroglutamine and methods fo their preparation and use

Publications (1)

Publication Number Publication Date
MX2012001921A true MX2012001921A (es) 2012-04-30

Family

ID=43586525

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001921A MX2012001921A (es) 2009-08-14 2010-08-13 Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso.

Country Status (9)

Country Link
US (1) US8747809B2 (es)
EP (1) EP2464223A1 (es)
JP (1) JP2013501813A (es)
KR (1) KR20120089846A (es)
CN (1) CN102595888A (es)
AU (1) AU2010282334A1 (es)
MX (1) MX2012001921A (es)
SG (1) SG178393A1 (es)
WO (1) WO2011020018A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11534494B2 (en) * 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
CN103333079B (zh) * 2013-07-03 2016-08-17 广东回旋医药科技股份有限公司 亚氨基酸类pet显像剂及其制备方法与应用
US20220001034A1 (en) * 2014-06-30 2022-01-06 Ge Healthcare Limited Novel formulation and method of synthesis
CN105152960B (zh) * 2015-10-11 2017-04-19 北京脑重大疾病研究院 一种18f ‑(2s,4r)‑4‑氟‑l‑谷胺酰胺的自动化制备方法及其装置
CN109369445B (zh) * 2018-11-20 2021-10-15 首都医科大学 用于诊断和治疗的放射性谷氨酰胺衍生物及其制备方法
WO2024135746A1 (ja) * 2022-12-20 2024-06-27 Ａｇｃ株式会社 抗がん剤
CN115819298A (zh) * 2022-12-26 2023-03-21 北京富盛嘉华医药科技有限公司 一种对甲苯磺酰甲基异腈的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712418A (en) * 1989-10-23 1998-01-27 Research Corporation Technologies, Inc. Synthesis and use of amino acid fluorides as peptide coupling reagents
US7138538B2 (en) * 2000-04-14 2006-11-21 Solvay (Societe Anonyme) Process for the separation of enantiomers and enantiopure reagent
EP1923382A1 (de) 2006-11-18 2008-05-21 Bayer Schering Pharma Aktiengesellschaft [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
CA2667395C (en) * 2006-11-01 2016-05-10 Bayer Schering Pharma Aktiengesellschaft [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, their derivatives and their use and processes for their preparation
EP2123620A1 (en) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them

Also Published As

Publication number Publication date
US20120288444A1 (en) 2012-11-15
SG178393A1 (en) 2012-03-29
CN102595888A (zh) 2012-07-18
JP2013501813A (ja) 2013-01-17
AU2010282334A1 (en) 2012-04-05
WO2011020018A1 (en) 2011-02-17
EP2464223A1 (en) 2012-06-20
KR20120089846A (ko) 2012-08-14
US8747809B2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
MX2012001921A (es) Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso.
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
MX346608B (es) Compuestos de isoindol 5-sustituidos.
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
MX2010009646A (es) Agentes terapeuticos antivirales.
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
IL204437A (en) History of aryl cyclic profile and their use
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
MX2009013830A (es) Compuestos antivirales.
UA98494C2 (uk) Противірусні сполуки
UA95975C2 (ru) N-метиламинометилизоиндольные соединения, композиции, содержащие их, и способы их применения
MX2011007930A (es) Conjugados de insulina cristalina.
MX2011003473A (es) Composiciones para el cuidado bucal.
MX2011010451A (es) Derivados de oxadiazol.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
GB2497475A (en) Kits, components and methods for tissue reconstruction
UA86731C2 (ru) Делимая галеновая форма модифицированного высвобождения активного ингредиента
ITMI20091618A1 (it) Pezzo composito, nonche' impiego del pezzo composito
MX2009009291A (es) Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal